By Priya Mehta, PharmD, Clinical Pharmacist. Medically reviewed by Dr. Hassan Karimi, MD, Board-Certified Endocrinology.
Last August, a woman named Rachel in Phoenix left her compounded semaglutide vial on the kitchen counter while she ran errands. The thermostat read 84°F when she got home three hours later. "I just stood there holding the vial, Googling whether I'd wasted $300," she told her pharmacist during a callback. That call, and the confusion behind it, is exactly why this piece exists.
Here's the thing: the title question ("what happens if semaglutide gets warm?") is really a storage question, and the answer matters. But the bigger, more practical question most people searching this actually need answered is how to handle their compounded GLP-1 medication correctly from label to injection. That's what this guide covers, step by step, so you don't need six browser tabs open at once.
This article is part of the FormBlends ultimate guide to compounded tirzepatide and the Tirzepatide Cost & Access hub.
The short answer on temperature
Semaglutide is a peptide. Peptides are proteins. Proteins denature when they get too warm for too long, the same way an egg white turns from clear to opaque in a hot pan. You can't reverse it.
For compounded semaglutide vials, most pharmacies specify refrigeration (36°F to 46°F) and allow brief room-temperature excursions, typically under 77°F for up to 28 days once in use. Go beyond that, especially into the 80s or 90s, and the molecule starts degrading. The medication may lose potency without looking any different. No color change, no cloudiness, no obvious warning sign.
If your vial sat in a hot car, on a sunny windowsill, or next to the stove for more than a short window: don't inject. Call the pharmacy. A potentially underdosed injection isn't just a waste of money; unpredictable potency makes it impossible to manage your dose escalation accurately.
My honest take: if you're unsure whether the vial was compromised, replace it. The cost of one wasted vial is less than the cost of weeks of confused dosing data.
Key takeaways before you begin
- Compounded GLP-1 dosing math: dose in mg ÷ concentration in mg/mL = volume in mL. Multiply volume by 100 to get units on a U-100 syringe.
- The unit count changes any time the pharmacy ships a different concentration, even if the prescribed milligram dose stays the same.
- Standard tirzepatide escalation in SURMOUNT-1: 2.5 mg weekly for 4 weeks, then 5 mg, with 4-weekly step-ups as tolerated.
- Compounded tirzepatide is not FDA-approved. The FDA does not pre-review compounded medications for safety, effectiveness, or quality.
What to gather before your first injection
Before you uncap anything, have these items on the counter: your current pharmacy label (with the concentration printed clearly), a U-100 insulin syringe in the appropriate volume (typically 0.3 mL or 0.5 mL for compounded GLP-1 dosing), an alcohol prep pad, a sharps container, the prescribed dose written down on paper, and your prescriber's contact info.
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.
Try the BMI Calculator →Read the label twice. The two numbers that matter most are the concentration in mg/mL and the total fill volume. Concentration drives the math. Fill volume tells you how many doses are in the vial.
Verify the medication name, patient name, expiration date, and storage condition before each injection. If anything looks wrong, do not inject. Call the pharmacy.
The five-step injection protocol
1. Confirm the basics.
Right medication. Right patient. Right dose in milligrams (as written on the prescription). Right injection day in the dosing schedule. A useful habit: write the prescribed dose on a small sticker on the vial cap at first fill, so the number is visible every time the cap comes off. Skipping this step is the most common root cause of dosing errors.
The figures and protocols cited throughout this guide trace back to peer-reviewed publications and FDA prescribing information for the relevant brand-name products. Compounded formulations are not FDA-reviewed, and any practical guidance about compounded products reflects the standard clinical protocol for the underlying active ingredient.
2. Do the math.
Take the prescribed dose in milligrams, divide by the concentration in mg/mL, and the result is the volume in mL to draw. Multiply by 100 to convert to units on a U-100 syringe.
Write the result down. Don't trust memory, especially if multiple family members are on different doses.
If the calculation produces a fractional unit (say, 12.5 units), round to the nearest whole unit only after confirming with the prescriber. Do not improvise rounding decisions on your own.
3. Verify with a second check.
Read the dose back to yourself, or read it aloud to a family member or a pharmacist on a phone call, before drawing into the syringe. This step takes thirty seconds and catches roughly half of the would-be errors that reach the syringe in self-administered protocols. It's the highest-leverage thirty seconds in the whole process.
4. Inject carefully.
Clean the injection site with the alcohol prep pad. Wait for the site to dry. Pinch a fold of skin if needed (depending on injection-site fat depth). Insert the needle at 90 degrees, push the plunger smoothly, count to five with the needle still in place, then withdraw and dispose immediately into the sharps container.
Rotate among the abdomen, the front of the thigh, and the back of the upper arm across weeks. Avoid the area within two inches of the navel. Do not inject through clothing.
5. Document and reassess.
Record the date, dose in milligrams, units drawn, injection site, and any unusual symptoms. Review the log monthly with your prescriber. The log produces signal that a single injection never will: trends in tolerability, patterns of side effects relative to dose, and gaps in adherence.
Related reading
Where this falls apart: the three most common mistakes
Using last month's unit number when the pharmacy shipped a different concentration. This is far and away the most frequent error. New vial, new concentration, new math. Always re-read the label.
Same-site repetition. Injecting in the same spot week after week leads to nodules and lipohypertrophy (hardened fatty tissue under the skin). The medication absorbs unpredictably through damaged tissue. Rotate.
Ignoring storage conditions. Which brings us full circle. Leaving the vial out of the recommended temperature range doesn't always produce an obvious visual cue. When in doubt, call the pharmacy before injecting. (This is what Rachel in Phoenix eventually did. Her pharmacist told her to toss the vial.)
More from this cluster
- Mounjaro Cost Goodrx - Real Numbers
- Ozempic Cost At Walmart - Real Numbers
- Does anthem blue cross cover ozempic?
When to stop and call a clinician
Stop the medication and seek immediate care for any of the following: severe abdominal pain (especially radiating to the back, which can signal pancreatitis), persistent vomiting that prevents fluid intake, jaundice or right-upper-quadrant pain (suggesting gallbladder disease), signs of an allergic reaction (rash, swelling of the face or throat, difficulty breathing), severe dehydration, or thoughts of self-harm.
Call your prescriber within 24 to 48 hours for symptoms that aren't emergent but aren't resolving with routine measures: persistent nausea past two weeks at a stable dose, new vision changes, ongoing constipation despite hydration and fiber, or any new symptom you can't explain.
For non-urgent questions about dosing, timing, or routine side effects, schedule a follow-up rather than self-adjusting. Dose escalation and injection timing are protocol-driven. Changes should be made in coordination with the prescriber.
Putting the trial numbers in perspective
Trial averages compress enormous variance into a single number. SURMOUNT-1, for example, reported substantial differences in response within the same dose arm, which is the normal pattern across GLP-1 trials. Reading the published distribution behind the average is more useful than fixating on the average itself.
Real-world cohorts add even more variance, mostly from adherence and lifestyle differences. The right mental model: treat the trial number as a useful anchor, not a destination guaranteed to every patient.
Across the GLP-1 class, the strongest predictor of long-term outcome is months on therapy at or near the maintenance dose. Everything else, the brand you're on, the specific compounding pharmacy, the injection site you prefer, matters less than simply staying the course.
Frequently asked questions
Is this question something I should discuss with a clinician?
Yes. Any question that affects how a prescription medication is dosed, stored, or administered is worth raising with your prescriber. The information in this article is general education, not a substitute for individualized clinical guidance.
What if I drew the wrong number of units last week?
Stop, do not inject again, and contact your prescriber. If the medication has already been injected at the wrong dose, contact the prescriber for guidance. Do not "make up" a dose without explicit instructions.
Does the unit count change if the pharmacy ships a different concentration?
Yes. The unit count is derived from the concentration. A new concentration means a new unit count, even if the milligram dose is the same. Always re-read the label.
Can I use a different syringe than the one the pharmacy provided?
Use only the syringe size and type specified by your pharmacy. A U-100 insulin syringe is standard for the most common compounded GLP-1 concentrations. Substituting a different syringe changes the calibration and is a known source of errors.
Is compounded tirzepatide FDA-approved?
No. Compounded tirzepatide is not an FDA-approved drug. The FDA does not review compounded medications for safety, effectiveness, or quality prior to dispensing. Compounded medications are dispensed under personalized prescriptions through state-licensed pharmacies when a prescriber determines a personalized formulation is clinically appropriate.
What actually happens to the semaglutide molecule when it gets warm?
The active peptide begins to degrade. Prolonged heat exposure breaks down the protein structure, reducing potency. The medication may look identical but deliver a lower effective dose. There's no reliable home test for this, so the safe move is to discard any vial exposed to temperatures above the pharmacy's stated range for longer than the specified window.
Continue the series
Important Safety Information
This article is for educational purposes only and is not medical advice. Compounded tirzepatide and compounded semaglutide are not FDA-approved drugs. The FDA does not review compounded medications for safety, effectiveness, or quality before they are sold. Compounded medications should only be used when a licensed prescriber determines a personalized formulation is clinically appropriate. Do not start, stop, or modify any prescription medication without speaking with a licensed healthcare provider. If you experience symptoms of a serious reaction, including severe abdominal pain, signs of pancreatitis, vision changes, persistent vomiting, signs of an allergic reaction, or thoughts of self-harm, seek emergency care immediately.
FormBlends sells only compounded semaglutide and compounded tirzepatide through licensed U.S. pharmacies after a telehealth evaluation by an independent prescriber. Eligibility, pricing, and formulation are determined on a case-by-case basis.
About this article
Written by Priya Mehta, PharmD (Clinical Pharmacist). Medically reviewed by Dr. Hassan Karimi, MD (Board-Certified Endocrinology). FormBlends content is reviewed by licensed U.S. clinicians prior to publication. The clinical decisions described above are general education only and should not replace individualized advice from your own healthcare provider.